Jack W. Schuler - 20 Dec 2023 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 May 2024, 15:58:14 UTC
Prior SEC filing
20 Dec 2023
Next SEC filing
03 Jan 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jack W. Schuler

Key filing fact

Jack W. Schuler filed Form 4 for YIELD10 BIOSCIENCE, INC. on 17 May 2024.

Key facts

  • This page summarizes Jack W. Schuler's Form 4 filing for YIELD10 BIOSCIENCE, INC..
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 17 May 2024, 15:58.

Change

  • Previous filing in this sequence was filed on 20 Dec 2023.
  • Current net transaction value: -$7,200.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

YTEN transaction

Common Stock

Sale

Transaction value
$7,200
Shares
-36,000
Change %
-36%
Price
$0.2000
Shares after
63,789
Date
20 Dec 2023
Ownership
By Jack W. Schuler Living Trust
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This late filing is due to an inadvertent administrative error.

Footnote F2

On May 2, 2024 the Issuer effected a 1-for-24 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities beneficially owned following the transaction reported herein has been adjusted and approximated to reflect the Reverse Stock Split.

Footnote F3

Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .